230 millions de personnes utilisent déjà ChatGPT pour leur santé !

230 millions de personnes utilisent déjà ChatGPT pour leur santé !

230 million people already use ChatGPT for their health!

🎙 Carlos Diaz 👥 99K 📅 March 14, 2026 ⏱ 76 min 👁 82K 📄 news review 🧭 2026-10-16
Available in: English (current) Français

Keywords

AIhealthChatGPTlongevitywearable

Summary

This episode of Silicon Carne discusses the growing use of ChatGPT for health queries, citing 230 million weekly users. The panel explores OpenAI’s new health feature, the challenges of medical data privacy in Europe, and the failure of previous tech giants in healthcare. They cover the rise of AI-powered medical diagnostics, startups like Nabla and Open Evidence, and the potential of brain-wave sensors and neurostimulation for Alzheimer’s. The conversation also touches on aging populations, longevity research, and robot-assisted care for seniors. The tone is enthusiastic about AI’s potential but raises concerns about data sovereignty and the need for human oversight.

100 words

Critical Evaluation

Value of the Information & Strength of the Argument

The show provides a rich overview of current AI health trends, with practical anecdotes and insights from people directly involved in startups. However, the argumentation often relies on enthusiasm rather than rigorous evidence, and the lack of a clinician reduces the depth of medical evaluation. The value lies in highlighting immediate changes in consumer behavior and industry movement, but the scientific validity of some claims is not thoroughly scrutinized.

Scientific Rigor, Source Quality, Title Accuracy

The scientific rigor is moderate: while several industry figures and product names are mentioned, concrete studies or verifiable data are rarely provided. Sources mainly consist of the hosts’ professional networks and personal experiences. The title adequately matches the main anecdote, but the episode’s scope is wider than that figure. Overall, the information is presented in a engaging but not deeply evidence-based manner.

146 words

Title / Content Match

The title focuses on a striking statistic that anchors the episode, but the discussion covers a much broader set of topics, making the title somewhat narrow yet still representative of the core theme.

Quality & Reliability

6/10

The conversation is engaging and up-to-date, featuring practitioners and entrepreneurs, but it lacks direct scientific sourcing and medical counterpoints, relying largely on personal anecdotes and industry claims.

Chapters

Cited Sources

  • Silicon Carne Substack — Official Substack for episode notes and community
  • Silicon Carne Podcast on Ausha — Podcast version of the show
  • Arnaud Auger LinkedIn — Guest profile
  • Carlos Diaz LinkedIn — Host profile
  • Clément Pouget Osmont LinkedIn — Guest profile
  • Wallerand Moullé-Berteaux LinkedIn — Guest profile

Concurring Sources

  • Nabla — Startup assisting physicians with AI scribing, mentioned positively
  • Open Evidence — AI tool for doctors to find clinical studies

Dissenting Sources

  • No direct contradicting sources were provided in the video — The video did not include opposing views or critical references from medical authorities.

External References

Contribution & Novelties

The episode brings fresh insights into how ChatGPT is reshaping patient behavior and the healthcare market, while also contextualizing the European regulatory gap. It uniquely combines perspectives from startup founders, investors, and a longevity advocate, offering a multifaceted view of AI’s incursion into health.

Pour aller plus loin :

  • ChatGPT — Background on the AI assistant’s capabilities and adoption.
  • Artificial intelligence in healthcare — Overview of AI applications in medicine.
  • Geroscience — Field studying the biology of aging, relevant to longevity discussions.
  • Insilico Medicine (no URL certain) — Company mentioned as using AI for drug discovery, notable for its IPO.

100 words

Radar Profile

The radar shows high quantity of information but moderate quality and technical depth. Reliability is lower due to lack of citations. The overall profile suggests an engaging but opinion-driven discussion rather than a rigorous scientific review.

Reliability 5/10

💬 Très positif avec quelques réserves. Sur les 30 commentaires analysés, la majorité félicite l'épisode et demande plus de contenu de ce type, mais plusieurs appellent à inviter un médecin pour un contrepoint, et certains expriment des inquiétudes sur la confidentialité des données.